Literature DB >> 25813339

Muscular dystrophy in a family of Labrador Retrievers with no muscle dystrophin and a mild phenotype.

Natassia M Vieira1, Ling T Guo2, Elicia Estrela1, Louis M Kunkel1, Mayana Zatz3, G Diane Shelton4.   

Abstract

Animal models of dystrophin deficient muscular dystrophy, most notably canine X-linked muscular dystrophy, play an important role in developing new therapies for human Duchenne muscular dystrophy. Although the canine disease is a model of the human disease, the variable severity of clinical presentations in the canine may be problematic for pre-clinical trials, but also informative. Here we describe a family of Labrador Retrievers with three generations of male dogs having markedly increased serum creatine kinase activity, absence of membrane dystrophin, but with undetectable clinical signs of muscle weakness. Clinically normal young male Labrador Retriever puppies were evaluated prior to surgical neuter by screening laboratory blood work, including serum creatine kinase activity. Serum creatine kinase activities were markedly increased in the absence of clinical signs of muscle weakness. Evaluation of muscle biopsies confirmed a dystrophic phenotype with both degeneration and regeneration. Further evaluations by immunofluorescence and western blot analysis confirmed the absence of muscle dystrophin. Although dystrophin was not identified in the muscles, we did not find any detectable deletions or duplications in the dystrophin gene. Sequencing is now ongoing to search for point mutations. Our findings in this family of Labrador Retriever dogs lend support to the hypothesis that, in exceptional situations, muscle with no dystrophin may be functional. Unlocking the secrets that protect these dogs from a severe clinical myopathy is a great challenge which may have important implications for future treatment of human muscular dystrophies.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal model; Canine; Myopathy

Mesh:

Substances:

Year:  2015        PMID: 25813339     DOI: 10.1016/j.nmd.2015.02.012

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  12 in total

1.  Immunoglobulin therapy ameliorates the phenotype and increases lifespan in the severely affected dystrophin-utrophin double knockout mice.

Authors:  Bruno Ghirotto Nunes; Flávio Vieira Loures; Heloisa Maria Siqueira Bueno; Erica Baroni Cangussu; Ernesto Goulart; Giuliana Castello Coatti; Elia Garcia Caldini; Antonio Condino-Neto; Mayana Zatz
Journal:  Eur J Hum Genet       Date:  2017-10-27       Impact factor: 4.246

2.  Pathogenic variants in COL6A3 cause Ullrich-like congenital muscular dystrophy in young Labrador Retriever dogs.

Authors:  Véronique Bolduc; Katie M Minor; Ying Hu; Rupleen Kaur; Steven G Friedenberg; Samantha Van Buren; Ling T Guo; Joseph C Glennon; Katia Marioni-Henry; James R Mickelson; Carsten G Bönnemann; G Diane Shelton
Journal:  Neuromuscul Disord       Date:  2020-04-16       Impact factor: 4.296

3.  Muscular dystrophy-dystroglycanopathy in a family of Labrador retrievers with a LARGE1 mutation.

Authors:  G Diane Shelton; Katie M Minor; Ling T Guo; Steven G Friedenberg; Jonah N Cullen; Jeffrey M Hord; David Venzke; Mary E Anderson; Megan Devereaux; Sally J Prouty; Caryl Handelman; Kevin P Campbell; James R Mickelson
Journal:  Neuromuscul Disord       Date:  2021-07-28       Impact factor: 4.296

Review 4.  Molecular circuitry of stem cell fate in skeletal muscle regeneration, ageing and disease.

Authors:  Albert E Almada; Amy J Wagers
Journal:  Nat Rev Mol Cell Biol       Date:  2016-03-09       Impact factor: 94.444

5.  Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure.

Authors:  M V Pelatti; J P A Gomes; N M S Vieira; E Cangussu; V Landini; T Andrade; M Sartori; L Petrus; Mayana Zatz
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

Review 6.  The golden retriever model of Duchenne muscular dystrophy.

Authors:  Joe N Kornegay
Journal:  Skelet Muscle       Date:  2017-05-19       Impact factor: 4.912

7.  Gait characterization in golden retriever muscular dystrophy dogs using linear discriminant analysis.

Authors:  Bodvaël Fraysse; Inès Barthélémy; El Mostafa Qannari; Karl Rouger; Chantal Thorin; Stéphane Blot; Caroline Le Guiner; Yan Chérel; Jean-Yves Hogrel
Journal:  BMC Musculoskelet Disord       Date:  2017-04-12       Impact factor: 2.362

Review 8.  Stem Cell Differentiation Toward the Myogenic Lineage for Muscle Tissue Regeneration: A Focus on Muscular Dystrophy.

Authors:  Serge Ostrovidov; Xuetao Shi; Ramin Banan Sadeghian; Sahar Salehi; Toshinori Fujie; Hojae Bae; Murugan Ramalingam; Ali Khademhosseini
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 6.692

9.  Dysphagia and esophageal dysfunction due to dystrophin deficient muscular dystrophy in a male Spanish water spaniel.

Authors:  Brigitte B McAtee; Johanna C Heseltine; Ling T Guo; Michael D Willard; G Diane Shelton
Journal:  Vet Q       Date:  2018-12       Impact factor: 3.320

10.  Dystrophin Exon 29 Nonsense Mutations Cause a Variably Mild Phenotype.

Authors:  Rebecca S Moore; Sandya Tirupathi; Brian Herron; Andrew Sands; Patrick J Morrison
Journal:  Ulster Med J       Date:  2017-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.